Skip to Content

Pharmaceuticals, Volume 7, Issue 5

2014 May - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
11 Citations
12,112 Views
26 Pages

14 May 2014

In general, prodrugs are developed to circumvent deficiencies associated with the absorption, distribution, metabolism, excretion or toxicological (ADMET) profile associated with the active drug. In our study, we select bupropion, a drug with broad p...

(This article belongs to the Special Issue Prodrugs: from Design to Clinic)
  • Article
  • Open Access
35 Citations
12,464 Views
13 Pages

14 May 2014

Kryptofix® 2.2.2 (Kry) or tetrabutylammonium (TBA) are commonly used as phase transfer catalysts in 18F-radiopharmaceutical productions for positron emission tomography (PET). Due to their toxicity, quality control has to be performed before adminis...

(This article belongs to the Special Issue Radiopharmaceutical Chemistry between Imaging and Radioendotherapy)
  • Review
  • Open Access
478 Citations
43,943 Views
50 Pages

13 May 2014

As the key components of innate immunity, human host defense antimicrobial peptides and proteins (AMPs) play a critical role in warding off invading microbial pathogens. In addition, AMPs can possess other biological functions such as apoptosis, woun...

(This article belongs to the Special Issue Identification and Characterization of Antimicrobial Peptides with Therapeutic Potential)
  • Article
  • Open Access
63 Citations
8,226 Views
15 Pages

7 May 2014

Biologics such as rituximab are an important component of oncology treatment strategies, although access to such therapies is challenging in countries with limited resources. This study examined access to rituximab and identified potential barriers t...

  • Article
  • Open Access
39 Citations
14,247 Views
13 Pages

Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep

  • Benjamin Baur,
  • Christoph Solbach,
  • Elena Andreolli,
  • Gordon Winter,
  • Hans-Jürgen Machulla and
  • Sven N. Reske

29 April 2014

Since prostate-specific membrane antigen (PSMA) has been identified as a diagnostic target for prostate cancer, many urea-based small PSMA-targeting molecules were developed. First, the clinical application of these Ga-68 labelled compounds in positr...

(This article belongs to the Special Issue Radiopharmaceutical Chemistry between Imaging and Radioendotherapy)
  • Article
  • Open Access
45 Citations
8,605 Views
15 Pages

Enhanced Antimicrobial Activity of AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the Scorpion Venom Peptide AamAP1

  • Ammar Almaaytah,
  • Shadi Tarazi,
  • Ahmad Abu-Alhaijaa,
  • Yara Altall,
  • Nizar Alshar'i,
  • Khaldon Bodoor and
  • Qosay Al-Balas

25 April 2014

There is great interest in the development of antimicrobial peptides as a potentially novel class of antimicrobial agents. Several structural determinants are responsible for the antimicrobial and cytolytic activity of antimicrobial peptides. In our...

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247